Center for Personalized Cancer Therapy

at the University of Massachusetts Boston

About Us

The Center for Personalized Cancer Therapy (CPCT) is a joint program of the University of Massachusetts Boston and the Dana Farber/Harvard Cancer Center (DF/HCC).

The goals of the center are to:

  1. Create research support platforms to facilitate high impact translational cancer research (academic and startup biotech companies).
  2. Focus research efforts on the development, validation, and commercialization of RNA- and protein-based cancer biomarkers with significant clinical utility: tumor subtyping and early measures of tumor response to therapy.
  3. Train and bring diverse student talent into DF/HCC.
  4. Provide UMass Boston students with skills suitable for academic careers or employment in regional biomedical industry.

The CPCT will provide a means for undergraduate and graduate students to become the next generation of well-trained biomedical workforce talent and the future leaders of life sciences research in academia and industry. 

A scientific focus of the center will be to elucidate how lifestyle choices, particularly those that promote diet-induced obesity and type 2 diabetes mellitus (‘diabesity’), modulate the tumor microenvironment, and how such modulation affects tumor initiation, progression, and response to therapy.

Learn more about the CPCT

Check out our presentation! Read More 

CPCT in the Mass Media News

Read More 

CPCT in The RISC Quarterly

Read More